Acclimating Practice to the Current Treatment Landscape in Follicular Lymphoma: Emerging Evidence and Recent Results

Watch a CME-certified webcast and download the slides from a live, expert-led webinar to get up to date on the latest clinical trial data informing optimal management of relapsed/refractory follicular lymphoma, including review of recent studies reported ASH 2022.

Share

Program Content

Relapsed/Refractory FL Update
Acclimating Practice to the Current Treatment Landscape in Follicular Lymphoma: Emerging Evidence and Recent Results
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 10, 2023

Expires: March 09, 2024

View Activity
2L Tx/3L+ Epigenetic Modifiers and PI3Ki
Recent Updates in the Management of Relapsed/Refractory Follicular Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2023

Expires: February 01, 2024

View Activity
3L+ IO Options
Newer Immunotherapy Options for Relapsed/Refractory Follicular Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2023

Expires: February 01, 2024

View Activity
ExpressPoints
ExpressPoints Acclimating Practice to the Current Treatment Landscape in FL: Emerging Evidence and Recent Results
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2023

Expires: February 15, 2024

View Activity

Faculty

cover img faculity

Ian W. Flinn, MD, PhD

Director, Lymphoma Research 
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

MEI Pharma Inc